Evidence map›Paper›PMID 41652904›Full record

ArticleThe FEBS journal2026

Energetic stress in combination with impaired fatty acid oxidation induces sequestration of CoA and adaptation of CoA metabolism.

Ligia Akemi Kiyuna, Christoff Odendaal, Madhulika Singh, Albert Gerding, Miriam Langelaar-Makkinje, Marianne van der Zwaag, Asmara Drachman, Vladimíra Cetkovská, Gaby Liem Foeng Kioen, Anne-Claire M F Martines and 8 more

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ligia Akemi KiyunaLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Christoff OdendaalLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.ORCID https://orcid.org/0000-0003-2199-5070
Madhulika SinghM Leiden Academic Centre for Drug Research, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Albert GerdingLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Miriam Langelaar-MakkinjeLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Marianne van der ZwaagBiomedical Sciences/ERIBA, University Medical Centre Groningen, University of Groningen, The Netherlands.
Asmara DrachmanM Leiden Academic Centre for Drug Research, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Vladimíra CetkovskáM Leiden Academic Centre for Drug Research, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Gaby Liem Foeng KioenM Leiden Academic Centre for Drug Research, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Anne-Claire M F MartinesLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Nicolette C A HuijkmanLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Hein SchepersBiomedical Sciences/ERIBA, University Medical Centre Groningen, University of Groningen, The Netherlands.
Bart van de SluisLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Dirk-Jan ReijngoudLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.
Ody C M SibonBiomedical Sciences/ERIBA, University Medical Centre Groningen, University of Groningen, The Netherlands.
Amy C HarmsM Leiden Academic Centre for Drug Research, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Thomas HankemeierM Leiden Academic Centre for Drug Research, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Barbara M BakkerLaboratory of Paediatrics, University of Groningen, University Medical Centre Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-6274-3633

Funding

H2020 Marie Skłodowska-Curie Actions 812616
6 · The paper itself

Abstract

Coenzyme A (CoA) is a vital cofactor involved in 8-10% of all metabolic reactions in human cells. Different inherited enzyme deficiencies in which the oxidation of acyl-CoAs is hampered have been hypothesised to share a phenotype characterised by toxic accumulation of acyl-CoA and a concomitant decline in free CoA (CoASH) levels, whereby CoASH becomes limiting for other metabolic reactions. This is referred to as CoASH sequestration. There is, however, limited experimental evidence for this hypothesis. Using a combination of approaches, we test this hypothesis in medium-chain acyl-CoA dehydrogenase deficiency (MCADD), the most common deficiency of mitochondrial fatty acid oxidation (mFAO), under energetic stress. Both in vitro MCAD-knockout (KO) HepG2 cells and a kinetic model of mFAO showed decreased CoASH, elevated medium-chain acyl-CoA, and decreased long-chain acyl-CoA levels. MCAD-KO mice exposed to fasting and cold as energetic stressors had a significantly increased total CoA pool and increased expression of CoA biosynthetic enzymes in the liver, indicative of an upregulated CoA biosynthesis. Expression of carnitine acyltransferases and acyl-CoA thioesterases, enzymes that liberate CoASH from acyl-CoAs, was also upregulated, suggesting an adaptive response of CoA metabolism to decreased CoASH. Finally, computational model simulations showed that a combination of elevated total CoA and thioesterase activity led to normalisation of both CoASH and medium-chain acyl-CoA levels. Together, the results provide the first evidence for the CoA sequestration hypothesis in MCADD. The observed adaptation of CoA metabolism under energetic stress may act as a compensatory response that counteracts CoASH depletion and accumulation of toxic medium-chain acyl-CoAs.

Indexed as

Acyl-CoA DehydrogenaseCoenzyme AEnergy MetabolismFatty AcidsLipid Metabolism, Inborn ErrorsStress, PhysiologicalAcyl Coenzyme AAnimalsHep G2 CellsHumansLiverMiceMice, KnockoutOxidation-ReductionAcyl-CoA DehydrogenaseAcyl Coenzyme ACoenzyme AFatty AcidsCASTORCoA metabolisminborn errors of metabolismMCAD deficiencysystems medicine

Identifiers

PMID41652904
PMCPMC13278353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.